Novelix Pharmaceuticals Ltd

📊 Novelix Pharma Q3 FY26 Results Board Meeting Scheduled

- Board meeting scheduled for February 12, 2026 to discuss unaudited standalone financial results for Q3 ending December 31, 2025

- Approval of equity shares allotment through preferential basis to be considered

- Trading window closed for designated persons and immediate relatives from January 1, 2026 until 48 hours after board meeting

- Company: Novelix Pharmaceuticals Limited (formerly Trimurthi Limited), Scrip Code: 536565